Moderna's mRNA Flu Shot Earns FDA Approval for Adults 50 and Up

Biotechnology

7 August 2026 at 5:57 am

Moderna's mRNA Flu Shot Earns FDA Approval for Adults 50 and Up

HyperFast News

Summary

Moderna's mRNA flu shot, mRNA-1010 (mFLUSIVA), has received FDA approval for adults aged 50 and up, marking the first mRNA flu vaccine to be approved. The approval follows a unanimous vote by FDA advisors and comes despite significant political challenges from anti-vaccine advocates.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.

FAQ

Newsroom FAQs

About the public HyperFast News news feed powered by NewsEngine.